Accelovance is a clinical research site located in South Bend, Indiana, United States 46601.
Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.
Accelovance has participated in 8 clinical trials.
Therapeutic areas: Pneumococcal Infections, Nocturia, Plague.
Sponsors: Pfizer, Ferring Pharmaceuticals, PharmAthene UK Limited.
Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Accelovance has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Accelovance has 8 clinical trials on record. Their work covers Pneumococcal Infections, Nocturia, Plague.
Yes — Accelovance holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.